Despite the introduction of new generics and the increasing pressure on prices of fixed-dose combinations (FDC), the French market of HIV drugs declined by only 2% in 2017 in comparison to 2016.
INSTI-based FDC market grew up by 17% and reached € 39.7 million for the whole year 2017.
Generics market share reached 4.1% in value and 13% in volume in December 2017.
France HIV drugs monthly statistics by class, type and name of product in Excel format (reused databases & sources: Medic'AM, AMELI):


Discussion entre l'organisation et la communauté à propos de ce jeu de données.